Pricing Log in Create free account

Abivax SA Sponsored ADR (ABVX) vs Oruka Therapeutics, Inc. (ORKA)

Abivax SA Sponsored ADR and Oruka Therapeutics, Inc. are both Biotechnology companies. Abivax SA Sponsored ADR is the larger, with a market value of $7.4B against $6.4B — 1.2× the size. Across the 10 metrics below, Oruka Therapeutics, Inc. leads on 8 and Abivax SA Sponsored ADR on 2.

Valuation

Metric ABVX ORKA Biotechnology median
P/E n/m n/m 10.26
P/S n/m n/m 9.18
P/B 15.83 5.47 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m n/m 0.65
EV/Sales n/m n/m 8.98
Earnings yield (7.16%) (2.19%) (34.89%)
Free cash flow yield (3.35%) (1.66%) (24.52%)

Profitability

Metric ABVX ORKA Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (249.78%) (18.30%) (50.12%)
Return on assets (137.67%) (17.76%) (45.60%)
Return on invested capital 0.00% (40.22%) 0.00%

Growth

Metric ABVX ORKA Biotechnology median
Revenue growth (TTM) — — 6.26%
EPS growth (last fiscal year) (80.20%) 52.20% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ABVX ORKA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 5.97 38.51 4.89
Net debt to EBITDA 2.19 2.65 1.01

Dividend

Metric ABVX ORKA Biotechnology median
Dividend yield — 0.00% 0.41%
Payout ratio — — —

Size

Metric ABVX ORKA Biotechnology median
Market cap 7.37b 6.36b 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack